Home  /  Resource Library  /  A Phase II, Multicenter, Single Arm, Open Label Study of Parsaclisib, a PI3K Inhibitor, in Relapsed or Refractory Follicular Lymphoma in China

A Phase II, Multicenter, Single Arm, Open Label Study of Parsaclisib, a PI3K Inhibitor, in Relapsed or Refractory Follicular Lymphoma in China

ASH 2021